174 related articles for article (PubMed ID: 34466770)
1. Response to rituximab in children and adults with immune thrombocytopenia (ITP).
Harris EM; Hillier K; Al-Samkari H; Berbert L; Grace RF
Res Pract Thromb Haemost; 2021 Aug; 5(6):e12587. PubMed ID: 34466770
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for children with immune thrombocytopenia: a systematic review.
Liang Y; Zhang L; Gao J; Hu D; Ai Y
PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
[TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
[TBL] [Abstract][Full Text] [Related]
4. Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia.
Grace RF; Bennett CM; Ritchey AK; Jeng M; Thornburg CD; Lambert MP; Neier M; Recht M; Kumar M; Blanchette V; Klaassen RJ; Buchanan GR; Kurth MH; Nugent DJ; Thompson AA; Stine K; Kalish LA; Neufeld EJ
Pediatr Blood Cancer; 2012 Feb; 58(2):221-5. PubMed ID: 21674758
[TBL] [Abstract][Full Text] [Related]
5. Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients.
Ding B; Liu L; Li M; Song X; Zhang Y; Xia A; Liu J; Zhou H
Platelets; 2023 Dec; 34(1):2258988. PubMed ID: 37722393
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study.
Mageau A; Bonnotte B; Ebbo M; Dossier A; Galicier L; Souchaud-Debouverie O; Orvain C; Gerfaud-Valentin M; Gobert D; Riviere E; Audia S; Mahevas M; Michel M; Viallard JF; Godeau B
Platelets; 2023 Dec; 34(1):2200848. PubMed ID: 37128870
[TBL] [Abstract][Full Text] [Related]
7. B-cell depletion in immune thrombocytopenia.
Godeau B
Semin Hematol; 2013 Jan; 50 Suppl 1():S75-82. PubMed ID: 23664523
[TBL] [Abstract][Full Text] [Related]
8. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.
Arnold DM; Dentali F; Crowther MA; Meyer RM; Cook RJ; Sigouin C; Fraser GA; Lim W; Kelton JG
Ann Intern Med; 2007 Jan; 146(1):25-33. PubMed ID: 17200219
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta-analysis of prospective clinical trials.
Ayad N; Grace RF; Al-Samkari H
Pediatr Blood Cancer; 2022 Mar; 69(3):e29447. PubMed ID: 34962697
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes and chronicity predictors for primary immune thrombocytopenia: 10-year data from an academic center.
Jaime-Pérez JC; Aguilar-Calderón P; Jiménez-Castillo RA; Ramos-Dávila EM; Salazar-Cavazos L; Gómez-Almaguer D
Ann Hematol; 2020 Nov; 99(11):2513-2520. PubMed ID: 32945941
[TBL] [Abstract][Full Text] [Related]
12. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.
Patel VL; Mahévas M; Lee SY; Stasi R; Cunningham-Rundles S; Godeau B; Kanter J; Neufeld E; Taube T; Ramenghi U; Shenoy S; Ward MJ; Mihatov N; Patel VL; Bierling P; Lesser M; Cooper N; Bussel JB
Blood; 2012 Jun; 119(25):5989-95. PubMed ID: 22566601
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients.
Gobert D; Bussel JB; Cunningham-Rundles C; Galicier L; Dechartres A; Berezne A; Bonnotte B; DeRevel T; Auzary C; Jaussaud R; Larroche C; LeQuellec A; Ruivard M; Seve P; Smail A; Viallard JF; Godeau B; Hermine O; Michel M
Br J Haematol; 2011 Nov; 155(4):498-508. PubMed ID: 21981575
[TBL] [Abstract][Full Text] [Related]
14. Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
Rivière E; Thiébaut R; Lazaro E; Guy A; James C; Mansier O; Blanco P; Viallard JF
Br J Haematol; 2023 Jul; 202(1):159-167. PubMed ID: 37081607
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
16. The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia.
Wang YM; Yu YF; Liu Y; Liu S; Hou M; Liu XG
Hematology; 2020 Dec; 25(1):139-144. PubMed ID: 32167032
[No Abstract] [Full Text] [Related]
17. Rituximab versus Splenectomy in Chronic Primary ITP: Experience of a Single Hematology Clinic.
Shamoon RP; Yassin AK; Alnuaimy SL
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024019. PubMed ID: 38468837
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
Oved JH; Lee CSY; Bussel JB
J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
[TBL] [Abstract][Full Text] [Related]
19. Profound symptomatic hypogammaglobulinemia: a rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
Levy R; Mahévas M; Galicier L; Boutboul D; Moroch J; Loustau V; Guillaud C; Languille L; Fain O; Bierling P; Khellaf M; Michel M; Oksenhendler E; Godeau B
Autoimmun Rev; 2014 Oct; 13(10):1055-63. PubMed ID: 25183241
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
